Advances in biological therapies for dyslipidemias and atherosclerosis.
Sign Up to like & getrecommendations! Published in 2020 at "Metabolism: clinical and experimental"
DOI: 10.1016/j.metabol.2020.154461
Abstract: Atherosclerosis is a multifactorial disease influenced by genetics, lifestyle and environmental factors. Despite therapeutic advances that reduce the risk of cardiovascular events, atherosclerosis-related diseases remain the leading cause of mortality worldwide. Precise targeting of genes… read more here.
Keywords: advances biological; therapies dyslipidemias; atherosclerosis; biological therapies ... See more keywords